AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deckelbaum, R. J
Right arrow Articles by Seo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deckelbaum, R. J
Right arrow Articles by Seo, T.
Agricola
Right arrow Articles by Deckelbaum, R. J
Right arrow Articles by Seo, T.
American Journal of Clinical Nutrition, Vol. 83, No. 6, S1520-1525S, June 2006
© 2006 American Society for Nutrition


Supplement: n–3 Fatty Acids: Recommendations for Therapeutics and Prevention

n–3 Fatty acids and gene expression1,2,3,4

Richard J Deckelbaum, Tilla S Worgall and Toru Seo

1 From the Institute of Human Nutrition (RJD, TSW, and TS), the Department of Pediatrics (RJD, TSW, and TS), and the Department of Pathology (TSW), College of Physicians & Surgeons of Columbia University, New York, NY

ABSTRACT

Accumulating evidence in both humans and animal models clearly indicates that a group of very-long-chain polyunsaturated fatty acids, the n–3 fatty acids (or omega-3), have distinct and important bioactive properties compared with other groups of fatty acids. n–3 Fatty acids are known to reduce many risk factors associated with several diseases, such as cardiovascular diseases, diabetes, and cancer. The mechanisms whereby n–3 fatty acids affect gene expression are complex and involve multiple processes. As examples, n–3 fatty acids regulate 2 groups of transcription factors, such as sterol-regulatory-element binding proteins and peroxisome proliferator-activated receptors, that are critical for modulating the expression of genes controlling both systemic and tissue-specific lipid homeostasis. Modulation of specific genes by n–3 fatty acids and cross-talk between these genes are responsible for many effects of n–3 fatty acids.

Key Words: Fatty acid • gene expression • EPA • eicosapentaenoic acid • DHA • docosahexaenoic acid • SREBP • sterol-responsive-element binding protein • PPAR • peroxisome proliferator-activated receptor




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum
n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. J. Wanten and P. C Calder
Immune modulation by parenteral lipid emulsions
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1171 - 1184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition